Expertise in
10
conditions

Dr. Philip M. Ginsburg

Gastroenterology
HHC Physician Services PLLC
2200 Whitney Ave Ste 360, 
Hamden, CT 
Expertise in
10
conditions
HHC Physician Services PLLC
2200 Whitney Ave Ste 360, 
Hamden, CT 

Overview

Philip Ginsburg is a Gastroenterologist practicing medicine in Hamden, Connecticut.

Dr. Ginsburg is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hemorrhagic Proctocolitis, Ulcerative Colitis, Crohn's Disease, Colonic Malakoplakia, and Gastrectomy.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 7 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in CT

Hospital Affiliations

Yale-New Haven Hospital
Rutland Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

HHC Physician Services PLLC
2200 Whitney Ave Ste 360, Hamden, CT 06518
Other Locations
Office
1591 Boston Post Rd Ste 206, Guilford, CT 06437

Additional Areas of Focus

Dr. Ginsburg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Other
Study Phase: Phase 4
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
Enrollment Status: Terminated
Publish Date: June 07, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 5 Less Clinical Trials

4 Total Publications

Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.
Journal: Crohn's & colitis 360
Published: December 11, 2023
Similar Doctors
Expertise in
14
conditions
Dr. Michael L. Schilsky
Gastroenterology
Expertise in
14
conditions
Dr. Michael L. Schilsky
Gastroenterology
Referral may be required

Yale University School Of Medicine

333 Cedar St, 
New Haven, CT 
 (8.9 miles away)
203-785-6140
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Schilsky is a Gastroenterologist practicing medicine in New Haven, Connecticut. Dr. Schilsky is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Wilson Disease, Liver Failure, Menkes Disease, Liver Transplant, and Endoscopy.

Expertise in
13
conditions
Dr. Joseph K. Lim
Gastroenterology
Expertise in
13
conditions
Dr. Joseph K. Lim
Gastroenterology
Referral may be required

Yale University School Of Medicine

333 Cedar St, 
New Haven, CT 
 (8.9 miles away)
203-785-4138
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joseph Lim is a Gastroenterologist practicing medicine in New Haven, Connecticut. Dr. Lim is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Hepatitis B, Liver Transplant, and Endoscopy.

Expertise in
14
conditions
Dr. Loren A. Laine
Gastroenterology
Expertise in
14
conditions
Dr. Loren A. Laine
Gastroenterology
Referral may be required

Va Connecticut Hcs-West Haven

950 Campbell Ave, 
West Haven, CT 
 (10.4 miles away)
203-937-3462
Languages Spoken:
English
See accepted insurances

Loren Laine is a Gastroenterologist practicing medicine in West Haven, Connecticut. Dr. Laine is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Gastrointestinal Bleeding, Heartburn, Esophageal Varices, Endoscopy, and Colonoscopy.

Frequently Asked Questions about Dr. Philip M. Ginsburg

How do I make an appointment with Dr. Philip M. Ginsburg?

You can book an appointment with Dr. Philip M. Ginsburg by calling their office at 203-281-4463. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Philip M. Ginsburg a top-rated expert for Hemorrhagic Proctocolitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Philip M. Ginsburg is classified as an Distinguished expert for Hemorrhagic Proctocolitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Philip M. Ginsburg specialize in?

While Dr. Philip M. Ginsburg is a Gastroenterology, they have specific expertise in Hemorrhagic Proctocolitis, Ulcerative Colitis, and Crohn's Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Philip M. Ginsburg participate in research or clinical trials?

Yes. Dr. Philip M. Ginsburg has published 4 articles and abstracts on conditions like Hemorrhagic Proctocolitis. You can view a list of Dr. Philip M. Ginsburg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Philip M. Ginsburg accept my insurance?

Dr. Philip M. Ginsburg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 203-281-4463 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ginsburg's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile